Mølholm Hansen J, Skovsted L, Kampmann J P, Lumholtz B I, Siersbaek-Nielsen K
Acta Pharmacol Toxicol (Copenh). 1978 May;42(5):343-6. doi: 10.1111/j.1600-0773.1978.tb02214.x.
The metabolism of phenytoin was studied in 9 hyperthyroid and 7 hypothyroid patients before and after treatment with either antithyroid drugs or 1-thyroxine. No difference in the half-life, volume of distribution and metabolic clearance rate was found between untreated hyper- and hypothyroid subjects. Furthermore, normalisation of thyroid function test did not change the kinetic parameters of phenytoin. The results indicate that the well-known correlation between thyroid function and antipyrine kinetics cannot be extrapolated uncritically to other drugs. It is concluded that no general rules are valid in the kinetics among different drugs in thyroid pathological conditions. Each drug must be evaluated by itself in different pathological conditions.
在9名甲状腺功能亢进患者和7名甲状腺功能减退患者中,研究了在使用抗甲状腺药物或左甲状腺素治疗前后苯妥英的代谢情况。未经治疗的甲状腺功能亢进和减退受试者之间,在半衰期、分布容积和代谢清除率方面未发现差异。此外,甲状腺功能测试的正常化并未改变苯妥英的动力学参数。结果表明,甲状腺功能与安替比林动力学之间的众所周知的相关性不能不加批判地外推到其他药物。得出的结论是,在甲状腺病理状态下,不同药物的动力学中不存在普遍适用的规则。每种药物都必须在不同的病理状态下单独进行评估。